ENVERIC BIOSCIENCES, INC. Total Liabilities and Equity
ENVERIC BIOSCIENCES, INC. (ENVB) had Total Liabilities and Equity of $8.94 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $8.94M.
- 2026-03-31: Liabilities and Equity $5.52M.
- 2025-12-31: Liabilities and Equity $5.10M.
- 2025-09-30: Liabilities and Equity $4.36M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $8.94M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $5.52M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.10M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $4.36M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $3.55M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $5.10M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.08M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $4.79M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $6.05M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $8.85M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $4.30M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $6.62M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $9.80M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $15.85M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $19.55M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $30.86M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $28.57M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $32.18M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $26.72M 10-K/A · filed 2023-06-09 | |
| 2021-09-30 | $69.76M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $23.69M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $25.79M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $4.10M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $27.99M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $27.51M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $27.14M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $108.79K 10-K · filed 2021-04-01 | $25.01M 10-K · filed 2020-03-25 |
| 2019-09-30 | $29.79M 10-K/A · filed 2020-08-12 | $26.66M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $27.00M 10-K/A · filed 2020-08-12 | $29.48M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $30.51M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $29.64M 10-K/A · filed 2020-08-12 | |
| 2018-09-30 | $45.90M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $45.54M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $47.92M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $52.20M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $47.14M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $47.29M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $49.68M 10-Q/A · filed 2017-05-15 | |
| 2016-12-31 | $39.51M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $38.12M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $15.14M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $12.63M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $13.83M 10-K/A · filed 2017-04-04 | |
| 2015-09-30 | $21.21M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $10.44M 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $4.46M 10-KT · filed 2016-03-15 | $3.90K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $5.08K 10-Q · filed 2015-05-14 | |
| 2014-09-30 | $9.13K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $12.01K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $3.44M 10-KT · filed 2016-03-15 | $26.69K 10-Q/A · filed 2014-05-08 |
| 2013-12-31 | $4.47K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $4.90K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $6.65K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $5.38K 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $5.60K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $6.37K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $6.42K 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $10.30K 10-Q/A · filed 2012-05-10 | |
| 2011-12-31 | $22.45K 10-K · filed 2013-02-28 | |
| 2011-09-30 | $24.38K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $8.06K 10-Q · filed 2011-08-02 | |
| 2010-12-31 | $1.13K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |